🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open label, multicenter phase III trial comparing the...
Status
Completed
Location
Moores UC San Diego Cancer Center
Start Date
2019-05-09
Trial ID
NCT03570892
Randomized phase III trial to compare the effectiveness of different chemot...
Status
Completed
Location
Children's Oncology Group
Start Date
1996-08
Trial ID
NCT00002798
RATIONALE: Drugs used in chemotherapy, such as fludarabine, work in differe...
Status
Completed
Location
Hamatologische/Onkologische Gemeinschaftspraxis - Augsburg
Start Date
2004-09
Trial ID
NCT00281892
Treatments Being Tested
The aim of this phase III trial is to assess the safety and efficacy of tre...
Status
Unknown
Location
German Low Grade Study Group (Glsg)
Start Date
1998-11
Trial ID
NCT00317096
Treatments Being Tested
This study proposes the use of a reduced intensity chemotherapy/radiation t...
Status
Completed
Location
Columbia University Medical Center
Start Date
2002-09
Trial ID
NCT01019876
The goal of this clinical research study is to learn if lenalidomide, when ...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2009-05-06
Trial ID
NCT00899431
Background: * One way to treat certain cancers of the blood and immune sys...
Status
Completed
Location
Childrens National Medical Center
Start Date
2011-04-19
Trial ID
NCT01338987
The purpose of this study was to confirm the clinical benefit observed in t...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04-14
Trial ID
NCT01313689
Treatments Being Tested
This is a clinical trial that will compare survival and sickle related outc...
Status
Completed
Location
Benioff Children's Hospital at Oakland
Start Date
2017-03-16
Trial ID
NCT02766465
In this study, patients were randomly assigned to either receive fludarabin...
Status
Completed
Location
GOELAMS
Start Date
1996-06
Trial ID
NCT00925873
Treatments Being Tested